Security National Bank of Sioux City Iowa’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.26M Sell
14,969
-363
-2% -$80.5K 1.92% 12
2025
Q4
$3.5M Sell
15,332
-50
-0.3% -$11.4K 2.25% 10
2025
Q3
$3.56M Buy
15,382
+45
+0.3% +$9.16K 2.32% 9
2025
Q2
$2.85M Buy
15,337
+1,948
+15% +$362K 2% 13
2025
Q1
$2.81M Sell
13,389
-128
-0.9% -$24.9K 2.04% 13
2024
Q4
$2.4M Sell
13,517
-6,116
-31% -$1.12M 1.68% 17
2024
Q3
$3.88M Buy
19,633
+6,257
+47% +$1.17M 2.37% 10
2024
Q2
$2.29M Sell
13,376
-292
-2% -$48.4K 1.65% 18
2024
Q1
$2.49M Sell
13,668
-86
-0.6% -$14.8K 1.75% 15
2023
Q4
$2.13M Sell
13,754
-200
-1% -$29.2K 1.61% 21
2023
Q3
$2.08M Sell
13,954
-265
-2% -$38.9K 1.62% 21
2023
Q2
$1.92M Buy
+14,219
New +$2.09M 1.44% 26
2022
Q4
$2.3M Buy
14,249
+251
+2% +$38.5K 1.76% 14
2022
Q3
$1.88M Sell
13,998
-25
-0.2% -$3.59K 1.67% 20
2022
Q2
$2.15M Sell
14,023
-70
-0.5% -$10.7K 1.83% 17
2022
Q1
$2.28M Sell
14,093
-1,073
-7% -$156K 1.7% 19
2021
Q4
$2.05M Buy
15,166
+260
+2% +$30.7K 1.41% 29
2021
Q3
$1.61M Buy
14,906
+897
+6% +$102K 1.24% 36
2021
Q2
$1.58M Sell
14,009
-155
-1% -$17.5K 1.24% 34
2021
Q1
$1.53M Sell
14,164
-118
-0.8% -$12.6K 1.24% 36
2020
Q4
$1.53M Sell
14,282
-160
-1% -$15.4K 1.31% 30
2020
Q3
$1.26M Sell
14,442
-145
-1% -$13.7K 1.19% 32
2020
Q2
$1.43M Buy
14,587
+62
+0.4% +$5.46K 1.54% 21
2020
Q1
$1.11M Buy
14,525
+670
+5% +$57.1K 1.43% 26
2019
Q4
$1.23M Buy
13,855
+60
+0.4% +$4.98K 1.2% 30
2019
Q3
$1.04M Hold
13,795
1.2% 32
2019
Q2
$1M Sell
13,795
-295
-2% -$23.2K 1.18% 30
2019
Q1
$1.14M Sell
14,090
-80
-0.6% -$6.54K 1.31% 28
2018
Q4
$1.31M Buy
14,170
+180
+1% +$15.8K 1.35% 29
2018
Q3
$1.32M Sell
13,990
-40
-0.3% -$3.79K 1.17% 41
2018
Q2
$1.3M Sell
14,030
-127
-0.9% -$12.4K 1.22% 37
2018
Q1
$1.34M Sell
14,157
-865
-6% -$95K 1.26% 37
2017
Q4
$1.45M Sell
15,022
-271
-2% -$25.5K 1.32% 34
2017
Q3
$1.36M Buy
15,293
+32
+0.2% +$2.44K 1.33% 33
2017
Q2
$1.11M Buy
15,261
+12
+0.1% +$807 1.09% 40
2017
Q1
$994K Sell
15,249
-409
-3% -$25.7K 0.98% 51
2016
Q4
$980K Buy
15,658
+136
+0.9% +$8.3K 1.02% 49
2016
Q3
$979K Sell
15,522
-200
-1% -$12.9K 1.09% 43
2016
Q2
$973K Buy
15,722
+10
+0.1% +$609 1.1% 43
2016
Q1
$897K Sell
15,712
-2,260
-13% -$126K 1.05% 46
2015
Q4
$1.06M Sell
17,972
-5
-0% -$288 1.05% 45
2015
Q3
$978K Sell
17,977
-85
-0.5% -$5.53K 1.15% 47
2015
Q2
$1.21M Buy
18,062
+1,264
+8% +$82.5K 1.32% 36
2015
Q1
$984K Sell
16,798
-30
-0.2% -$1.81K 1.06% 53
2014
Q4
$1.1M Sell
16,828
-289
-2% -$18.2K 1.23% 43
2014
Q3
$989K Sell
17,117
-160
-0.9% -$8.88K 1.11% 48
2014
Q2
$975K Buy
17,277
+70
+0.4% +$3.67K 1.1% 50
2014
Q1
$885K Sell
17,207
-20
-0.1% -$1.01K 1.04% 53
2013
Q4
$910K Sell
17,227
-141
-0.8% -$6.93K 1.1% 50
2013
Q3
$777K Sell
17,368
-31
-0.2% -$1.37K 1.13% 50
2013
Q2
$719K Buy
+17,399
New +$761K 1.12% 48

Other funds holding ABBV

Security National Bank of Sioux City Iowa's ABBV Position: Q1 2026 in Review

Security National Bank of Sioux City Iowa reduced its AbbVie (ABBV) stake by 2.4% in Q1 2026, selling an estimated $80.5K and leaving 14,969 shares worth $3.26M. The position accounts for 1.92% of the portfolio, ranked #12.

Security National Bank of Sioux City Iowa first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $3.88M in Q3 2024. 4,090 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Security National Bank of Sioux City Iowa held 14,969 shares of AbbVie worth $3.26M as of Q1 2026.
  • Security National Bank of Sioux City Iowa sold 363 AbbVie shares in Q1 2026, an estimated $80.5K.
  • AbbVie made up 1.92% of Security National Bank of Sioux City Iowa's portfolio in Q1 2026, its #12 holding.
  • Security National Bank of Sioux City Iowa first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
  • Security National Bank of Sioux City Iowa's AbbVie position peaked at $3.88M in Q3 2024.
  • 4,090 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Security National Bank of Sioux City Iowa's 13F filing for Q1 2026, filed 15 May 2026.